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Endoluminal embolization and revascularization
for complicated mesenteric pseudoaneurysms:
A report of two cases and a literature review
M. Todd Miller, MD, Anthony J. Comerota, MD, Robert DiSalle, MD, Allan Kaufman, MD,
and John P. Pigott, MD, Toledo, Ohio
Mesenteric artery pseudoaneurysms are a rare and complex complication after abdominal trauma, surgery, or inflamma-
tory disease. These lesions can be associated with compression or erosion into adjacent structures and may result in
life-threatening hemorrhage. Traditional management has been open surgical ligation, aneurysm resection with inter-
position grafts, or resection or partial resection of the end organ involved. We present two cases of endovascular repair of
complex mesenteric pseudoaneurysms. One patient presented with a recurrent pseudoaneurysm of the superior mesen-
teric artery and the second presented as recurrent gastrointestinal bleeding secondary to a traumatic celiac artery
pseudoaneurysm-to-pancreatic duct fistula. A systematic review of the literature on endovascular management of
mesenteric vascular disease and mesenteric pseudoaneurysms is included in this report to allow these cases to be put into
proper perspective. ( J Vasc Surg 2007;45:381-6.)Mesenteric artery pseudoaneurysm is a rare but com-
plex complication after abdominal trauma, mesenteric re-
vascularization, or inflammatory disease. These lesions can
result in compression or erosion of adjacent structures or
life-threatening hemorrhage. Traditional management has
been operative repair with an interposition graft or arterial
ligation and, if needed, resection or partial resection of the
end organ involved.1 Advances in technology have led to
endovascular approaches to these lesions. Reports have
emerged describing thrombin injection, embolization, or
stent graft exclusion, or a combination, in both individual
cases and small retrospective series. We present two patients
with mesenteric artery pseudoaneurysm and their subse-
quent endovascular management as well as a review of the
English literature illustrating an evolution of the manage-
ment of mesenteric pseudoaneurysm.
CASE REPORTS
Patient 1. A 79-year-old woman presented with acute wors-
ening of chronic abdominal pain and a large, tender, pulsatile mass
in her upper abdomen. Her medical history included aortoiliac
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doi:10.1016/j.jvs.2006.09.010disease, chronic mesenteric ischemia, and renal artery stenosis.
Prior vascular reconstructions included aortobifemoral and supe-
rior mesenteric artery (SMA) bypasses and left renal angioplasty
and stenting.
Seven months before admission, the patient underwent oper-
ative repair of a symptomatic SMA pseudoaneurysm with a poly-
tetrafluoroethylene (PTFE) interposition graft. Her recovery and
subsequent 7 months were uneventful until 3 days before admis-
sion, when she developed rapidly progressive abdominal discom-
Fig 1. The initial abdominal computed tomography scan shows a
pseudoaneurysm (arrow) of the superior mesenteric artery (SMA)
that recurred in a 79-year-old woman 7 months after a previous
open SMA pseudoaneurysm repair.fort, food intolerance, tachycardia, and a fall in her hematocrit.
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B, A postintervention arteriogram demonstrates successful exclusion of pseudoaneurysm by stent grafts.
aneurysm and arteriopancreatic duct fistula (arrows).
Fig 3. An abdominal computed tomography scan at 1 month
after the interventions shows a patent superior mesenteric artery
and excluded pseudoaneurysm (arrows).
arteriopancreatic duct fistula has been obliterated.
Fig 4. An abdominal computed tomography scan with contrast
shows a pseudoaneurysm of the celiac artery (arrows) in a 32-year-
old man who sustained a gunshot wound of the abdomen 6
months earlier. The patient presented with recurrent gastrointes-
tinal bleeding.Fig 5. Selective arteriogram of the celiac artery reveals a pseudo-Fig 6. A selective arteriogram of the celiac artery after coil embo-
lization of the left gastric artery and splenic artery and covered stent
graft of celiac trunk to common hepatic artery shows that the
ty; F/
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vealed a recurrent SMA pseudoaneurysm (Fig 1). The patient was
not septic and did not have radiologic or clinical evidence to
suggest infection as a cause for the recurrent pseudoaneurysm. We
therefore believed arterial wall degeneration at the site of distal
anastomosis was the likely cause.
An arteriogram demonstrated the SMA bypass graft and a
pseudoaneurysm at the distal anastomosis (Fig 2, A). The SMA
was cannulated, and multiple attempts to pass a 6-mm Viabahn
stent graft (W. L. Gore & Associates, Flagstaff, Ariz) into the SMA
Table I. Literature review: embolization experience
Year published Author Embol (n) Tech success
1987 Mandel4 19 79 (15
1987 Baker5 8 100 (8) 
1992 Salam6 16 81 (13
1993 Repasky7 1 100 (1) 
1996 Stambo8 8 88 (7) 
1998 Reber9 5 100 (5) 
1999 Hama10 1 100 (1) 
1999 de Perrot11 3 100 (3) 
2000 Carr12 6 67 (4) 
2000 Carrmeci13 9 56 (5) 
2001 Hossain14 8 100 (8) 
2001 Carr S3 4 100 (4) 
2001 Kasirajan15 12 75 (9) 
2002 Gabelmann16 25 92 (23
2002 Pilleul17 18 78 (14
2002 Parildar18 22 95 (21
2003 Flati19 1 100 (1) 
2003 Tessier20 2 100 (2) 
2004 Deshmukh21 30 97 (29
2004 Sessa22 13 100 (13
2005 Lau23 14 100 (14
2005 Saltzberg24 15 94 (14
Total — 240 89 (21
Embol, embolization; Conv, conversion; Comp, complication; Mort, mortali
Table II. Literature review: stent graft experience
Year Author Stents (N) Complications (%) D
1998 McGraw25 1 0 
2000 Nyman26 1 0 
2000 Paci27 1 0 
2001 Tan28 1 0 
2001 Yoon29 1 0 
2002 Venturini30 1 0 
2002 Rocˇek31 1 0 
2002 Cowan32 1 0 
2002 Larson33 2 0 
2002 Arepally34 1 0 
2002 Brountzos35 1 100 
2003 Appel36 1 0 
2003 Takahashi37 1 0 
2004 Ogino38 1 0 
2004 Seriki39 1 0 
2004 Gandini40 1 0 
2005 Qu41 1 0 
2005 Saltzberg24 3 0 
Total 21 1 (5)
Comp, Complications; F/U, follow-up.were unsuccessful owing to stent inflexibility and the femoralapproach. The left brachial artery was then cannulated; however,
the stent graft could not be properly positioned owing to the SMA
stenosis and inadequate catheter length.
It was thought that obliteration of the pseudoaneurysm
cavity would temporize the patient’s condition until a more
appropriately sized and flexible stent graft could be obtained.
Access into the pseudoaneurysm cavity was obtained with a
microcatheter system. The pseudoaneurysm was then obliter-
ated with coil embolization and thrombin injection. A comple-
tion arteriogram showed minimal contrast in the inferior por-
Conv Comp % (n) Mort % (n) F/U (months)
N/A N/A 0 N/A
3 13 (1) 0 N/A
0 8 (1) 0 8m
0 0 0 N/A
1 0 0 21
0 40 (2) 0 35
0 0 0 10
0 0 33 (1) N/A
2 50 (3) 11 (1) N/A
4 0 0 N/A
0 0 0 N/A
0 25 (1) 0 N/A
0 0 0 46
1 50 (12) 4 (1) 49
N/A N/A N/A 0.4
1 0 5 (1) 12
0 0 0 11
0 0 0 N/A
0 7 (2) 3 (1) N/A
0 15 (2) 0 N/A
0 50 (7) 14 (2) N/A
1 22 (3) 0 N/A
6 (13) 17 (34) 3 (7) 22
U, follow-up.
(%) Type F/U (mos) Clinical patency
Self-made 12 Y
Wallgraft 12 NA
Unknown 3 Y
Jostent 9 Y
Jostent  1 3 Y
Jostent 12 Y
Jostent 30 NA
Jostent 60 NA
Symbiot 13 NA
Jostent  3 4 Y
Hemobahn Wallstent 1 Y
Jostent & Wallgraft 6 NA
Gianturco Z 10 Y
Passager stent 24 Y
Jostent NA NA
Jostent 7 Y
Talent 60 Y
Viabahn NA NA
— 17 (avg) —% (n)
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0tion of the pseudoaneurysm (Fig 2, B ).
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for monitoring, with plans to obtain approval and consent for the
off-label use of a Jomed stent graft (Jomed International AB,
Helsingborg, Sweden). Interestingly, the patient’s symptoms had
resolved and her aneurysm was no longer pulsatile or tender.
Two days later two 5-mm  26-mm Jomed stent grafts were
successfully deployed, excluding the pseudoaneurysm (Fig 2, C).
The patient subsequently developed a symptomatic right common
femoral artery pseudoaneurysm that required operative repair, and
she also underwent thrombectomy and repair of a thrombosed left
brachial artery.
She was discharged on oral antibiotic therapy 7 days after the
stent graft procedure, tolerating a regular diet and without abdom-
inal pain. A follow-up CT scan 1 month later showed a patent graft
and no pseudoaneurysm (Fig 3). The patient remained asymptom-
atic for 7 months after the procedure, at which time she died of
myocardial infarction.
Patient 2. A 32-year-old man presented with recurrent gas-
trointestinal (GI) bleeding 7 months after a gunshot wound to his
abdomen. During the exploratory laparotomy at the time of his
injury, a retroperitoneal hematoma in the area of the pancreas was
observed and sutures were placed to control bleeding. His recovery
was complicated by a pancreatic leak that was successfully treated
with bowel rest and hyperalimentation.
During the next 6 months, he was hospitalized on four occa-
sions for GI bleeding requiring blood transfusions. Results of
esophagogastroduodenoscopy, colonoscopy, and small bowel follow-
through were negative on each hospitalization. On his fifth hospi-
talization for the same problem, he underwent a bleeding scan,
which was negative. A CT scan of the abdomen and pelvis demon-
strated what appeared to be a pseudoaneurysm of the celiac artery
(Fig 4), which was confirmed arteriographically.
The patient had no symptoms or signs of sepsis and no
radiologic findings suggesting an infected pseudoaneurysm. The
pseudoaneurysm had a wide neck and appeared to arise from the
anterior portion of the celiac artery at its junction with the com-
mon hepatic artery, measuring 11 13mm. Injection of the celiac
artery demonstrated the source of the GI bleeding was a commu-
nication of the pseudoaneurysm with the pancreatic duct resulting
in hemosuccus pancreaticus (Fig 5).
Operative repair was expected to be associated with significant
morbidity, so an endovascular approach was planned. The goal was
to exclude the pseudoaneurysm while maintaining hepatic perfu-
sion. Using a bilateral common femoral artery approach, the celiac
artery and SMA were cannulated. The celiac catheter was then
advanced into the proximal splenic artery and left gastric artery and
embolized with 5-mm and 2-mm coils, respectively, to prevent
backflow into the pseudoaneurysm. The common hepatic artery
was then cannulated and an 8-mm  40-mm Fluency stent (Bard
Peripheral Vascular, Tempe, Ariz) was placed in the hepatic artery
just proximal to the gastroduodenal artery and extended into the
celiac trunk. A completion arteriogram showed exclusion of the
pseudoaneurysm and obliteration of the arteriopancreatic fistula
(Fig 6).
The patient did well and was discharged 3 days later tolerating
a full diet. During the next year of follow-up, the patient had no
further GI bleeding. A mesenteric arterial duplex ultrasound ex-amination 18 months after the procedure demonstrated a patent
celiac stent and hepatic artery.
DISCUSSION
Opinions differ about management of aneurysms and
pseudoaneurysms of the visceral arteries. Interestingly, some
authors do not differentiate between true and false aneurysms.
Traditionally, mesenteric artery aneurysms and pseudoaneu-
rysms have beenmanaged with open surgical repair. Repair of
asymptomatic true aneurysms and pseudoaneurysms has been
advised because of the high likelihood of rupture and resultant
death. In one of the larger reports, 22% of patients with
visceral artery aneurysms presented as emergencies resulting in
9% mortality.2 A recent report indicates a more pessimistic
presentation and outcome, with 42% of visceral artery aneu-
rysm patients presenting with rupture resulting in 25% mor-
tality.3
During the last two decades, there has been a shift in
the management of these lesions. In the mid-1980s, case
reports and small series reported successful treatment of
mesenteric artery aneurysms and pseudoaneurysms with
embolization. Technical success was 56% to 100%, with
complication rates of 0% to 50% (Table I).3-24 In fact,
embolization alone was used to treat two-thirds of the
aneurysms and pseudoaneurysms found in our literature
review. Unfortunately, follow-up was poor and recanaliza-
tion and patency rates were sporadically recorded.
In the late 1990s, reports of exclusion with stent grafts
began to appear (Table II).24-41 All reported cases were
technical successes with no deaths and only one complica-
tion. A variety of stent grafts have been used; however,
most were Jomed stent grafts, as used in our first patient.
Follow-up was short-term and inconsistent.
Recently, reports of mesenteric pseudoaneurysms and
true aneurysms are focusing on endovascular management.
For pseudoaneurysms, the approach using embolization
and thrombin injection to obliterate the pseudoaneurysm,
followed by endoluminal stent grafting for optimal revas-
cularization, is developing a therapeutic foothold (Table
III).3,13-15,21-24 The mortality rate of endovascular treat-
ment is less than either open repair or medical manage-
ment. The success of the endovascular approach has led
some to endorse it as an alternative therapy for true
mesenteric artery aneurysms, even in the presence of
rupture.3,13-15,21-24 We recognize that successful reports
represent a bias in that technical failures and complica-
tions are rarely published.
Principles for endovascular management have been re-
fined during the last two decades, contributing to the safe
management of these patients. Sound management princi-
ples include the obliteration and exclusion of the aneurysm
or pseudoaneurysm with maintenance of distal perfusion
and obliteration of side branches. Magnetic resonance im-
aging or CT establishes the diagnosis and a management
strategy can be planned. Selective arteriography reveals the
details necessary for precise management. Identifying col-
lateral and major branches, sizing vessels, and maintaining
guidewire access are important principles.
ort, m
2% (4
JOURNAL OF VASCULAR SURGERY
Volume 45, Number 2 Miller et al 385Early in the evolution of endovascular procedures, em-
bolization alone gained therapeutic favor. This is accom-
plished with coils, gel foam, thrombin, or a combination of
these. The drawback of embolization alone is potential
recanalization and recurrence of the pseudoaneurysm. The
gastroduodenal artery has been reported to be the most
common focal source of visceral artery aneurysm rupture
and is usually amenable to arterial embolization. The most
effective technique of arterial embolization is occlusion of
the artery distal and proximal to the aneurysm.3
When occlusion of the vessel is not possible, direct
embolization of the pseudoaneurysm, as was done in our
first case, is recommended, assuming the pseudoaneurysm
does not have a short, wide neck, which increases the risk of
inadvertent vessel thrombosis or embolization. In these
situations, stent grafts appear to be the preferred endovas-
cular approach, thereby excluding the pseudoaneurysm and
preserving distal perfusion. Unfortunately, the options for
stent grafts are limited and the smaller diameter of these
vessels is problematic. Drawbacks associated with stent
grafts are the diameter of the target vessel, the difficult
trackability, and the need for large access sheaths. Although
covered stent grafts are available for cardiac angioplasty
rescue, these are often not readily available in peripheral
endovascular units.
Long-term follow-up of endovascular interventions for
mesenteric artery aneurysms and pseudoaneurysms is not
available. A prudent course of follow-up should include
clinical evaluation combined with some form of imaging
modality, including ultrasonography, CT, magnetic reso-
nance angiography, and duplex subtraction angiography. It
Table III. Literature review: contemporary management
Year Author Study dates N
2000 Carmecci13 1980-1998 31 
2001 Kasirajan15 1988-1998 9 
2001 Carr S3 1990-2000 26 
2001 Hossain14 1983-1998 30 
2003 Tessier21 1980-1998 10 
2004 Sessa22 1975-2002 34 
2005 Saltzberg24 1990-2003 65 
Total 205
VAA, Visceral artery aneurysms; Open, open repair; Comp, complications; M
*Medical treatment (nonoperative/no endovascular procedure).
Table III. Continued
Endo % (n) Comp % (n) Mort % M
26 (9) 0 0
61 0 0 1
15 (4) 0 25% (1) 2
27 (8) 25 (2) 0 1
20 (2) NA 0
31 (13) 23 (5) 0
28 (18) 20 (4) 0 5
29 (60) 15 (9) 0.2% (1) 2seems reasonable that timing of follow-up imaging besimilar to that used for aortic endograft repair, generally at
1 month, 6 months, and annually thereafter, assuming
normal findings.
CONCLUSION
We report two cases of endovascular management of
complicated mesenteric pseudoaneurysms, with one pre-
senting as recurrent gastrointestinal hemorrhage from a
celiac artery to pancreatic duct fistula. The good early
results of these complicated patients, avoiding serious mor-
bidity, supports an initial endovascular approach for these
patients. Combining embolization, where appropriate,
with stent graft revascularization will likely maximize suc-
cess. Long-term follow-up is important to assess the proper
role of endovascular management in these patients.
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